Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lederman, Howard
NEAT, NCT06193200: Evaluate the Neurological Effects of EryDex on Subjects With A-T	Recruiting	3	106	Europe, US	Dexamethasone sodium phosphate, DSP, Placebo	Quince Therapeutics S.p.A., Biotrial	Ataxia Telangiectasia	08/25	09/25
OLE_NEAT, NCT06664853: Open-Label Extension of EryDex Study IEDAT-04-2022	Recruiting	3	106	Europe, US	Dexamethasone sodium phosphate	Quince Therapeutics S.p.A., Biotrial	Ataxia Telangiectasia	11/26	11/26